Kasprzak-Drozd, K.; Niziński, P.; Kasprzak, P.; Kondracka, A.; Oniszczuk, T.; Rusinek, A.; Oniszczuk, A.
Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)? Int. J. Mol. Sci. 2024, 25, 3746.
https://doi.org/10.3390/ijms25073746
AMA Style
Kasprzak-Drozd K, Niziński P, Kasprzak P, Kondracka A, Oniszczuk T, Rusinek A, Oniszczuk A.
Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)? International Journal of Molecular Sciences. 2024; 25(7):3746.
https://doi.org/10.3390/ijms25073746
Chicago/Turabian Style
Kasprzak-Drozd, Kamila, Przemysław Niziński, Paulina Kasprzak, Adrianna Kondracka, Tomasz Oniszczuk, Agata Rusinek, and Anna Oniszczuk.
2024. "Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)?" International Journal of Molecular Sciences 25, no. 7: 3746.
https://doi.org/10.3390/ijms25073746
APA Style
Kasprzak-Drozd, K., Niziński, P., Kasprzak, P., Kondracka, A., Oniszczuk, T., Rusinek, A., & Oniszczuk, A.
(2024). Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)? International Journal of Molecular Sciences, 25(7), 3746.
https://doi.org/10.3390/ijms25073746